Varicella zoster virus (VZV) is an important human pathogen that is restricted to growth in human tissues and cells. The primary goal of this project is to learn how VZV grows in human skin, and what effects it has on the intracellular environment of skin cells. Our hypothesis is that the molecular interaction of VZV with the host is fundamentally different in skin organ culture than in cultured cells. We will approach this issue by developing the skin organ culture (SOC) model of VZV replication, study the assembly of VZV in this skin model, and test the phenotype of VZV mutants. The SOC model will also allow us to study the effects of VZV infection on the host cells.
Our second aim i s to investigate the effects of VZV infection on signal transduction pathways in skin cells. We will measure the level of tyrosine phosphorylation, an early event in signal transduction, and then use a panel of antibodies to study the three major downstream pathways. Finally, chemical inhibitors of the signal transduction kinases will be used to determine their effect on VZV replication. Ultimately, the skin organ culture model may help us improve vaccine safety by identifying VZV virulence genes, and provide new ideas for antiviral drugs that target viral and cellular proteins.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
5F31AI061848-03
Application #
7092600
Study Section
Special Emphasis Panel (ZRG1-ONC-O (29))
Program Officer
Hernandez, Milton J
Project Start
2004-08-21
Project End
2007-08-20
Budget Start
2006-08-21
Budget End
2007-08-20
Support Year
3
Fiscal Year
2006
Total Cost
$25,529
Indirect Cost
Name
Upstate Medical University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
058889106
City
Syracuse
State
NY
Country
United States
Zip Code
13210
Zapata, Heidi J; Nakatsugawa, Masako; Moffat, Jennifer F (2007) Varicella-zoster virus infection of human fibroblast cells activates the c-Jun N-terminal kinase pathway. J Virol 81:977-90